๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Pharmacokinetics of mycophenolate and its glucuronidated metabolites in stable lung transplant recipients

โœ Scribed by N. Partovi; L. Ting; M.H.H. Ensom; W. Riggs; R.D. Levy

Book ID
116518664
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
68 KB
Volume
24
Category
Article
ISSN
1557-3117

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Pharmacokinetics of mycophenolate mofeti
Pharmacokinetics of mycophenolate mofetil in stable pediatric liver transplant recipients receiving mycophenolate mofetil and cyclosporine
โœ Steven J. Lobritto; Philip Rosenthal; Rene Bouw; Mimi Leung; Paul Snell; Richard ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 152 KB

There are few pharmacokinetic data for mycophenolate mofetil (MMF) when used in combination with cyclosporine (CsA) in pediatric liver transplant recipients. The aim of this study was to assess the pharmacokinetics of MMF in stable pediatric liver transplant patients and estimate the dose of MMF req

Comparison of pharmacokinetics of mycoph
Comparison of pharmacokinetics of mycophenolic acid and its metabolites between living donor liver transplant recipients and deceased donor liver transplant recipients
โœ Shen Baiyong; Chen Bing; Zhang Weixia; Mao Huarong; Shen Chuan; Deng Xiaxing; Zh ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 236 KB

Living-donor liver transplantation (LDLT) has been considered an alternative method for treatment of patients with end-stage liver disease. However, the characteristics of pharmacokinetics of mycophenolic acid (MPA) in patients who underwent LDLT were not clear. This study was designed to compare th